Coronavirus situation under control in Delhi, not terrible, says Kejriwal
Maruti reports 54% YoY decline in sales in June; sells less than 40% of pre-coronavirus level
Government Bans 59 Chinese Apps Including Tik-Tok, Shareit, UC Browser, and WeChat
PM Modi to address the nation at 4 pm: What to expect
Maharashtra Extends Lockdown Till July 31 Day After Urging Caution
Coronavirus Vaccine Update
Swarms Of Desert Locusts Reach Delhi Outskirts After Gurugram
Delhi fighting difficult battle against COVID-19, will emerge victorious: Kejriwal
2-Week Lockdown In Guwahati From Monday; Minister Says "Shop By Sunday"
YouTube likely to come up with TikTok-like short video platform
Rs 2,000 crore from PM CARES Fund to be spent on 50,0000 ventilators for COVID-19 patients
Baba Ramdev's Patanjali launches India's 'first Ayurvedic' medicine for coronavirus, Coronil
Coronavirus: Glenmark conducts Fabiflu trial on 1,000 patients; to compete with Gilead's Remdesivir
Jio's golden touch makes Reliance Industries share rise 108% in 3 months
Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers
Chennai lockdown starts today: Check what is allowed, not allowed
Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19
India-China tension: Indian Army releases list of 20 martyrs; wreath ceremony begins in Leh
Tamil Nadu announces 'maximised restricted lockdown' from June 19 in Chennai, 3 other districts
Maruti Suzuki's Alto becomes India's top-selling car for 16th year in a row

Latest Posts

Coronavirus vaccine update: US firm Eli Lilly begins human trial of potential treatment

latest news update

US-based healthcare firm Eli Lilly and Co has said that it has begun with the world's first human trial of potential antibody treatment of coronavirus. The first set of patients have been dosed in an early-stage trial which is the world's first study of an antibody treatment against the disease. The study will assess safety and tolerability in patients hospitalised with coronavirus and results are anticipated by the end of June, the company said in a statement.

The experimental treatment, LY-CoV555, has been developed through collaboration with privately held AbCellera Biologics, which Lilly partnered with in March to test antibodies to treat and prevent coronavirus. Eli Lilly also said that it plans to move into the next phase of testing, studying the potential treatment in non-hospitalised patients, if the drug is shown to be safe.

Right now, over 100 experimental COVID-19 vaccines are in various stages of development, as per the World Health Organisation (WHO). From US-based Moderna Inc to China's CanSino Pharmaceuticals Inc, some of the world's biggest companies are in the race to develop the coronavirus vaccine.

"I still think that we have a good chance, if all the things fall in the right place, that we might have a vaccine that would be deployable by the end of the year, by December and November," Anthony Fauci, a key member of the White House coronavirus task force and globally renowned immunologist, recently said.

Meanwhile, there are 64,52,390 cases of coronavirus currently across the world. So far, 3,82,479 people have died from the disease.

×

Alert Message

Ok
Please Wait...

Share the Opinion Poll with your Friends At

Ok

Share the Survey with your
Friends At

Ok
×

Statistics

Ok
No
×

Statistics

Ok